Tortugas Neuroscience, Inc.
Clinical trials sponsored by Tortugas Neuroscience, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- First look: can a new tablet form of TRTL-729 pass safety checks? Results expected Jan 2027 (estimated)
- Can a new pill silence the ringing in your ears? Results expected Aug 2027 (estimated)
-
Can a new pill silence the ringing in your ears?
Symptom relief Not yet recruitingThis Phase 2a trial is testing an experimental drug called TRTL-913 to see if it is safe and might help reduce tinnitus, the perception of ringing or buzzing in the ears. The study has two parts: first, healthy adults will receive the drug or a placebo to check safety and how the…
Phase 2 • Sponsor: Tortugas Neuroscience, Inc. • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
First look: can a new tablet form of TRTL-729 pass safety checks?
Knowledge-focused Not yet recruitingResearchers are testing a new tablet form of the experimental drug TRTL-729 in about 10 healthy adults aged 18 to 55. Participants receive a single dose, and the team tracks side effects, vital signs, lab results, heart rhythm, and mood-related safety checks. Blood samples measur…
Phase 1 • Sponsor: Tortugas Neuroscience, Inc. • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC